What Are the Therapeutic Alternatives When a Janus Kinase Inhibitor Fails to Work? SAN DIEGO—Treatment alternatives after Janus kinase (JAK) inhibitor failure in real-life conditions were analyzed and presented at ACR Convergence 2023 by Pablo Francisco Muñoz MartĂnez, a rheumatologist at the Hospital Universitario y PolitĂ©cnico La Fe, Sagunto, Spain.1 JAK inhibitors are newer, targeted…
